Providing evidence-based information in a practical, easy-to-read format for practicing clinicians, investigators, industry scientists, and other entities involved in the field of neuroscience
Current Issue • July–September 2024
Risk Management: Top 25 Tips to Reduce Clinicians’ Stress Levels
by Donna Vanderpool, MBA, JD Ms. Vanderpool is the Director of Risk Management at Professional Risk Management Services (PRMS). Funding: No funding was provided for the preparation of this article. Disclosures: The author is an [...]
Letter to the Editor: Steroid Management in a Patient with Myasthenia Gravis Undergoing COVID-19 Vaccination
Funding/financial disclosures. The authors have no conflict of interest relevant to the content of this letter. No funding was received for the preparation of this letter. Innov Clin Neurosci. 2022;19(7–9):8. Dear Editor: We report [...]
Bipolar I Disorder Exacerbation Following COVID-19 Vaccination
by Jeffrey Guina, MD; Sara Barlow, BS; and Duren Gutierrez, DNP Dr. Guina and Ms. Barlow are with Oakland University William Beaumont School of Medicine in Rochester, Michigan. Drs. Guina and Gutierrez are with Easterseals [...]
Post-stroke Sexual Dysfunction in Men: Epidemiology, Diagnostic Work-up, and Treatment
by Rocco Salvatore Calabrò, MD, PhD Dr. Calabrò is with IRCCS Centro Neurolesi “Bonino-Pulejo” in Messina, Italy. Funding: No funding was provided for this article. Disclosures: The author has no conflicts of interest relevant to [...]
Personality Disorders in Patients with Intellectual Disability
by Julie P. Gentile MD, MBA; Nita V. Bhatt MD, MPH; Jesse P. Cannella, BS; Kari Harper, MD; and John Johnson, MD, MBA Dr. Gentile is Professor and Chair of the Department of Psychiatry at [...]
Pre-, Peri-, and Neonatal Factors Associated with Autism Spectrum Disorder: Results of a Lebanese Case-control Study
by Aline Hajj, PharmD, PhD; Souheil Hallit, PharmD, MSc, MPH, PhD; Rouba El-Khatib, PharmD; Sandra Abi Haidar, PharmD; Fabienne Hajj Moussa Lteif, MSc; Layal Hajj, MSc; Maguy Moudawar, MSc; and Lydia Rabbaa Khabbaz, PharmD, PhD [...]
Psychotherapy for Violent Behavior in Children and Adolescents
by Kari Harper, MD, and Julie P. Gentile, MD, MBA Dr. Harper is Assistant Professor and Assistant Training Director of Child/Adolescent Fellowship at Wright State University in Dayton, Ohio. Dr. Gentile is Professor and Chair [...]
Quantitative Characterization of the Smoothness of Extended-release Methylphenidate Pharmacokinetic Profiles
by Michelle D. Po, PhD; Roberto Gomeni, PhD, HDR, FCP; and Bev Incledon, PhD Dr. Po is with Highland Therapeutics Inc. in Toronto, Ontario, Canada. Dr. Gomeni is with PharmacoMetrica France in La Fouillade, France and [...]
Past Articles
Current and Emerging Technologies to Address the Placebo Response Challenge in CNS Clinical Trials: Promise, Pitfalls, and Pathways Forward
by William P. Horan, PhD; Gary Sachs, MD; Dawn I. Velligan, PhD; Michael Davis, MD, PhD; Richard S.E. Keefe, PhD; Ni A. Khin, MD; Florence Butlen-Ducuing, MD, PhD; and Philip D. Harvey, PhD Dr. Horan [...]
Health Anxiety, Fear of COVID-19, Nosophobia, and Health-protective Behaviors Among Healthcare Professionals
by Uzma Ilyas, PhD scholar; Farwa Aslam, MS; Muqadas Fatima, MS; Zarmin Tariq, MS; and Prof Dr. Usman Hotiana, MBBS, FCPS (Psychology) Ms. Ilyas is Principal Lecturer, Psychology Department, University of Central Punjab in Lahore, [...]
Psychotherapy’s Role in Evaluating the Invisible Wounds of Moral Injury
by Ben Onnink, MD; Matthew C. Correll, BS Candidate; Andrew Correll, BS, MD Candidate; and Terry Correll, DO Dr. Onnink is a resident, Department of Psychiatry, Wright State University Boonshoft School of Medicine in Dayton, [...]
Functioning and Cognition in Patients with Schizophrenia After Initiating Treatment with Aripiprazole Lauroxil: Secondary Outcomes and Post Hoc Analysis
by Mark G. A. Opler, PhD, MPH; Amy Claxton, PhD*; James McGrory, PhD; Sabina Gasper, MPH*; Meihua Wang, PhD*; and Sergey Yagoda, MD, PhD Dr. Opler is with WCG, Inc. in New York, New York. [...]
Ensuring Stakeholder Feedback in the Design and Conduct of Clinical Trials for Rare Diseases: ISCTM Position Paper of the Orphan Disease Working Group
by Gahan J. Pandina, PhD; Joan Busner, PhD; Lucas Kempf, MD; Joan Fallon, BS, DC; Larry D. Alphs, MD, PhD; Maria T. Acosta, MD; Anna-Karin Berger, PhD; Simon Day, PhD; Judith Dunn, PhD; Victoria Villalta-Gil, [...]
ChatGPT and Transcranial Direct Current Stimulation for Chronic Pain
by Edson Silva-Filho, PhD, and Rodrigo Pegado, PhD Both authors are with Graduate Program in Heath Science, Graduate Program in Physical Therapy, Federal University of Rio Grande do Norte in Rio Grande do Norte, Brazil. [...]
Genesis of Mental Disorders: Could It Be Cavum Septum Pellucidum (CSP) et Vergae? A Case Report of CSP in Schizophrenia with Catatonia
by Allison Zuckerberg, MD; Nitin Pothen, MD; and Adriana Fitzsimmons, MD Dr. Zuckerberg is with Department of Psychiatry, Temple University Hospital in Philadelphia, Pennsylvania. Dr. Pothen is with Department of Psychiatry, Ocean University Medical Center [...]
Risk Management: Blurring the Lines—Boundary Violation
by Akemini “Kem” Isang, RN, JD Ms. Isang is a Risk Manager at Professional Risk Management Services (PRMS). Funding: No funding was provided for the preparation of this article. Disclosures: The author is an employee [...]